Mechanistically, AGPG physically activated E2F1 via interacting with PURα and blocking the binding of E2F1 to PURα, while AGPG inhibition significantly repressed tumor growth in the endocrine-resistant mouse model (Yu et al., 2023). This evidence concerns the gene E2F1 and neoplasm.